Literature DB >> 26293498

Bronchiectasis in Germany: a population-based estimation of disease prevalence.

Felix C Ringshausen1, Andrés de Roux2, Roland Diel3, David Hohmann4, Tobias Welte5, Jessica Rademacher6.   

Abstract

Mesh:

Year:  2015        PMID: 26293498     DOI: 10.1183/13993003.00954-2015

Source DB:  PubMed          Journal:  Eur Respir J        ISSN: 0903-1936            Impact factor:   16.671


× No keyword cloud information.
  35 in total

1.  Mutagenic damage among bronchiectasis patients attending in the pulmonology sector of a hospital in southern Brazil.

Authors:  Daniel Wenceslau Votto Olmedo; Katheryne Benini Martins; Milene Machado Paz; Caroline Lopes Feijo Fernandes; Flavio Manoel Rodrigues da Silva Júnior; Daniela Fernandes Ramos
Journal:  Rev Assoc Med Bras (1992)       Date:  2022-09       Impact factor: 1.712

Review 2.  Intermittent prophylactic antibiotics for bronchiectasis.

Authors:  Sally Spencer; Tim Donovan; James D Chalmers; Alexander G Mathioudakis; Melissa J McDonnell; Anthony Tsang; Peter Leadbetter
Journal:  Cochrane Database Syst Rev       Date:  2022-01-05

3.  Association between exercise and risk of cardiovascular diseases in patients with non-cystic fibrosis bronchiectasis.

Authors:  Hayoung Choi; Sang Hyuk Kim; Kyungdo Han; Tai Sun Park; Dong Won Park; Ji-Yong Moon; Sang-Heon Kim; Tae-Hyung Kim; Jang Won Sohn; Ho Joo Yoon; Hyun Lee
Journal:  Respir Res       Date:  2022-10-18

Review 4.  Dual antibiotics for bronchiectasis.

Authors:  Lambert M Felix; Seamus Grundy; Stephen J Milan; Ross Armstrong; Haley Harrison; Dave Lynes; Sally Spencer
Journal:  Cochrane Database Syst Rev       Date:  2018-06-11

5.  Exercise training for bronchiectasis.

Authors:  Annemarie L Lee; Carla S Gordon; Christian R Osadnik
Journal:  Cochrane Database Syst Rev       Date:  2021-04-06

6.  The EMBARC European Bronchiectasis Registry: protocol for an international observational study.

Authors:  James D Chalmers; Stefano Aliberti; Eva Polverino; Montserrat Vendrell; Megan Crichton; Michael Loebinger; Katerina Dimakou; Ian Clifton; Menno van der Eerden; Gernot Rohde; Marlene Murris-Espin; Sarah Masefield; Eleanor Gerada; Michal Shteinberg; Felix Ringshausen; Charles Haworth; Wim Boersma; Jessica Rademacher; Adam T Hill; Timothy Aksamit; Anne O'Donnell; Lucy Morgan; Branislava Milenkovic; Leandro Tramma; Joao Neves; Rosario Menendez; Perluigi Paggiaro; Victor Botnaru; Sabina Skrgat; Robert Wilson; Pieter Goeminne; Anthony De Soyza; Tobias Welte; Antoni Torres; J Stuart Elborn; Francesco Blasi
Journal:  ERJ Open Res       Date:  2016-01-20

7.  The disease burden of bronchiectasis in comparison with chronic obstructive pulmonary disease: a national database study in Korea.

Authors:  Bumhee Yang; Hayoung Choi; Jun Hyeok Lim; Hye Yun Park; Danbee Kang; Juhee Cho; Jae Seung Lee; Sei Won Lee; Yeon-Mok Oh; Ji-Yong Moon; Sang-Heon Kim; Tae-Hyung Kim; Jang Won Sohn; Ho Joo Yoon; Hyun Lee
Journal:  Ann Transl Med       Date:  2019-12

Review 8.  Continuous versus intermittent antibiotics for bronchiectasis.

Authors:  Tim Donovan; Lambert M Felix; James D Chalmers; Stephen J Milan; Alexander G Mathioudakis; Sally Spencer
Journal:  Cochrane Database Syst Rev       Date:  2018-06-03

Review 9.  Macrolide antibiotics for bronchiectasis.

Authors:  Carol Kelly; James D Chalmers; Iain Crossingham; Nicola Relph; Lambert M Felix; David J Evans; Stephen J Milan; Sally Spencer
Journal:  Cochrane Database Syst Rev       Date:  2018-03-15

10.  Results from a large targeted screening program for alpha-1-antitrypsin deficiency: 2003 - 2015.

Authors:  Timm Greulich; Christoph Nell; Christian Herr; Claus Vogelmeier; Viktor Kotke; Stefan Wiedmann; Marion Wencker; Robert Bals; Andreas Rembert Koczulla
Journal:  Orphanet J Rare Dis       Date:  2016-06-10       Impact factor: 4.123

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.